- Home
- VSTA vs ENGN Comparison
VSTA vs ENGN Comparison
Compare VSTA & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTA
- ENGN
- Stock Information
- Founded
- VSTA 1966
- ENGN 1999
- Country
- VSTA Brazil
- ENGN Canada
- Employees
- VSTA N/A
- ENGN N/A
- Industry
- VSTA Other Consumer Services
- ENGN
- Sector
- VSTA Real Estate
- ENGN
- Exchange
- VSTA Nasdaq
- ENGN Nasdaq
- Market Cap
- VSTA 357.6M
- ENGN 297.7M
- IPO Year
- VSTA 2020
- ENGN N/A
- Fundamental
- Price
- VSTA $4.29
- ENGN $3.39
- Analyst Decision
- VSTA Sell
- ENGN Buy
- Analyst Count
- VSTA 2
- ENGN 7
- Target Price
- VSTA $3.00
- ENGN $23.29
- AVG Volume (30 Days)
- VSTA 67.8K
- ENGN 54.9K
- Earning Date
- VSTA 05-08-2025
- ENGN 06-13-2025
- Dividend Yield
- VSTA N/A
- ENGN N/A
- EPS Growth
- VSTA N/A
- ENGN N/A
- EPS
- VSTA 0.97
- ENGN N/A
- Revenue
- VSTA $270,690,068.00
- ENGN N/A
- Revenue This Year
- VSTA $14.44
- ENGN N/A
- Revenue Next Year
- VSTA $11.80
- ENGN N/A
- P/E Ratio
- VSTA $4.40
- ENGN N/A
- Revenue Growth
- VSTA 12.64
- ENGN N/A
- 52 Week Low
- VSTA $1.60
- ENGN $3.27
- 52 Week High
- VSTA $5.49
- ENGN $14.67
- Technical
- Relative Strength Index (RSI)
- VSTA 46.41
- ENGN 27.30
- Support Level
- VSTA $4.00
- ENGN $3.51
- Resistance Level
- VSTA $4.64
- ENGN $3.99
- Average True Range (ATR)
- VSTA 0.29
- ENGN 0.40
- MACD
- VSTA -0.10
- ENGN -0.00
- Stochastic Oscillator
- VSTA 26.66
- ENGN 10.71
About VSTA Vasta Platform Limited
Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.